Studies of anandamide accumulation inhibitors in cerebellar granule neurons

Comparison to inhibition of fatty acid amide hydrolase

Cecilia J. Hillard, Leyu Shi, Venugopal Raju Tuniki, J R Falck, William B. Campbell

Research output: Contribution to journalArticle

26 Citations (Scopus)

Abstract

The endocannabinoid, N-arachidonylethanolamine (AEA) is accumulated by neurons via a process that has been characterized biochemically but not molecularly. Inhibitors of AEA accumulation have been characterized individually but have not been compared in a single study. Our purpose was to compare the potency of five previously described compounds (AM404, AM1172, VDM11, OMDM-2, and UCM707) both as inhibitors of AEA and N-palmitoylethanolamine (PEA) accumulation by cerebellar granule neurons and as inhibitors of AEA hydrolysis. The compounds all inhibited AEA accumulation; AM404, VDM11 and OMDM-2 with IC50 values of approximately 5 μM, whereas AM1172 and UCM707 exhibited IC50 values of 24 and 30 μM, respectively. The compounds also inhibited PEA accumulation; AM404 being the most potent with an IC50 of 6 μM, whereas the other compounds had IC50 values in the range of 30-70 μM. All of the compounds potently inhibited AEA hydrolysis by brain membranes; the K I values for AM404, VDM11, and UCM707 were less than 1 μM; AM1172 and OMDM-2 exhibited K I values of 3 and 10 μM, respectively. The IC50 values for inhibition of AEA accumulation were compared to the IC50 values for PEA accumulation and AEA hydrolysis using linear regression. None of the regressions were significant. These data indicate that inhibition of AEA accumulation by neurons is not a result of the inhibition of endocannabinoid hydrolysis and is a process different from the accumulation of PEA. These studies support the hypothesis that the cellular AEA accumulation beyond simple equilibrium between intracellular and extracellular concentrations occurs because AEA binds to an intracellular protein that is not FAAH but that also recognizes the AEA uptake inhibitors.

Original languageEnglish (US)
Pages (from-to)18-24
Number of pages7
JournalJournal of Molecular Neuroscience
Volume33
Issue number1
DOIs
StatePublished - Sep 2007

Fingerprint

Inhibitory Concentration 50
Neurons
Hydrolysis
Endocannabinoids
Linear regression
Brain
Membranes
anandamide
fatty-acid amide hydrolase
N-(4-hydroxyphenyl)arachidonylamide
palmidrol
Linear Models
N-(2-methyl-3-hydroxyphenyl)-5,8,11,14-eicosatetraenamide
N-(3-furylmethyl)eicosa-5,8,11,14-tetraenamide
AM1172
Proteins

Keywords

  • AM1172
  • AM404
  • N-arachidonylethanolamine
  • OMDM-2
  • Palmitoylethanolamide
  • UCM707
  • VDM-11

ASJC Scopus subject areas

  • Neuroscience(all)
  • Biochemistry
  • Genetics

Cite this

Studies of anandamide accumulation inhibitors in cerebellar granule neurons : Comparison to inhibition of fatty acid amide hydrolase. / Hillard, Cecilia J.; Shi, Leyu; Tuniki, Venugopal Raju; Falck, J R; Campbell, William B.

In: Journal of Molecular Neuroscience, Vol. 33, No. 1, 09.2007, p. 18-24.

Research output: Contribution to journalArticle

Hillard, Cecilia J. ; Shi, Leyu ; Tuniki, Venugopal Raju ; Falck, J R ; Campbell, William B. / Studies of anandamide accumulation inhibitors in cerebellar granule neurons : Comparison to inhibition of fatty acid amide hydrolase. In: Journal of Molecular Neuroscience. 2007 ; Vol. 33, No. 1. pp. 18-24.
@article{a480fe4eacd64085882acd17e803ec25,
title = "Studies of anandamide accumulation inhibitors in cerebellar granule neurons: Comparison to inhibition of fatty acid amide hydrolase",
abstract = "The endocannabinoid, N-arachidonylethanolamine (AEA) is accumulated by neurons via a process that has been characterized biochemically but not molecularly. Inhibitors of AEA accumulation have been characterized individually but have not been compared in a single study. Our purpose was to compare the potency of five previously described compounds (AM404, AM1172, VDM11, OMDM-2, and UCM707) both as inhibitors of AEA and N-palmitoylethanolamine (PEA) accumulation by cerebellar granule neurons and as inhibitors of AEA hydrolysis. The compounds all inhibited AEA accumulation; AM404, VDM11 and OMDM-2 with IC50 values of approximately 5 μM, whereas AM1172 and UCM707 exhibited IC50 values of 24 and 30 μM, respectively. The compounds also inhibited PEA accumulation; AM404 being the most potent with an IC50 of 6 μM, whereas the other compounds had IC50 values in the range of 30-70 μM. All of the compounds potently inhibited AEA hydrolysis by brain membranes; the K I values for AM404, VDM11, and UCM707 were less than 1 μM; AM1172 and OMDM-2 exhibited K I values of 3 and 10 μM, respectively. The IC50 values for inhibition of AEA accumulation were compared to the IC50 values for PEA accumulation and AEA hydrolysis using linear regression. None of the regressions were significant. These data indicate that inhibition of AEA accumulation by neurons is not a result of the inhibition of endocannabinoid hydrolysis and is a process different from the accumulation of PEA. These studies support the hypothesis that the cellular AEA accumulation beyond simple equilibrium between intracellular and extracellular concentrations occurs because AEA binds to an intracellular protein that is not FAAH but that also recognizes the AEA uptake inhibitors.",
keywords = "AM1172, AM404, N-arachidonylethanolamine, OMDM-2, Palmitoylethanolamide, UCM707, VDM-11",
author = "Hillard, {Cecilia J.} and Leyu Shi and Tuniki, {Venugopal Raju} and Falck, {J R} and Campbell, {William B.}",
year = "2007",
month = "9",
doi = "10.1007/s12031-007-0045-0",
language = "English (US)",
volume = "33",
pages = "18--24",
journal = "Journal of Molecular Neuroscience",
issn = "0895-8696",
publisher = "Humana Press",
number = "1",

}

TY - JOUR

T1 - Studies of anandamide accumulation inhibitors in cerebellar granule neurons

T2 - Comparison to inhibition of fatty acid amide hydrolase

AU - Hillard, Cecilia J.

AU - Shi, Leyu

AU - Tuniki, Venugopal Raju

AU - Falck, J R

AU - Campbell, William B.

PY - 2007/9

Y1 - 2007/9

N2 - The endocannabinoid, N-arachidonylethanolamine (AEA) is accumulated by neurons via a process that has been characterized biochemically but not molecularly. Inhibitors of AEA accumulation have been characterized individually but have not been compared in a single study. Our purpose was to compare the potency of five previously described compounds (AM404, AM1172, VDM11, OMDM-2, and UCM707) both as inhibitors of AEA and N-palmitoylethanolamine (PEA) accumulation by cerebellar granule neurons and as inhibitors of AEA hydrolysis. The compounds all inhibited AEA accumulation; AM404, VDM11 and OMDM-2 with IC50 values of approximately 5 μM, whereas AM1172 and UCM707 exhibited IC50 values of 24 and 30 μM, respectively. The compounds also inhibited PEA accumulation; AM404 being the most potent with an IC50 of 6 μM, whereas the other compounds had IC50 values in the range of 30-70 μM. All of the compounds potently inhibited AEA hydrolysis by brain membranes; the K I values for AM404, VDM11, and UCM707 were less than 1 μM; AM1172 and OMDM-2 exhibited K I values of 3 and 10 μM, respectively. The IC50 values for inhibition of AEA accumulation were compared to the IC50 values for PEA accumulation and AEA hydrolysis using linear regression. None of the regressions were significant. These data indicate that inhibition of AEA accumulation by neurons is not a result of the inhibition of endocannabinoid hydrolysis and is a process different from the accumulation of PEA. These studies support the hypothesis that the cellular AEA accumulation beyond simple equilibrium between intracellular and extracellular concentrations occurs because AEA binds to an intracellular protein that is not FAAH but that also recognizes the AEA uptake inhibitors.

AB - The endocannabinoid, N-arachidonylethanolamine (AEA) is accumulated by neurons via a process that has been characterized biochemically but not molecularly. Inhibitors of AEA accumulation have been characterized individually but have not been compared in a single study. Our purpose was to compare the potency of five previously described compounds (AM404, AM1172, VDM11, OMDM-2, and UCM707) both as inhibitors of AEA and N-palmitoylethanolamine (PEA) accumulation by cerebellar granule neurons and as inhibitors of AEA hydrolysis. The compounds all inhibited AEA accumulation; AM404, VDM11 and OMDM-2 with IC50 values of approximately 5 μM, whereas AM1172 and UCM707 exhibited IC50 values of 24 and 30 μM, respectively. The compounds also inhibited PEA accumulation; AM404 being the most potent with an IC50 of 6 μM, whereas the other compounds had IC50 values in the range of 30-70 μM. All of the compounds potently inhibited AEA hydrolysis by brain membranes; the K I values for AM404, VDM11, and UCM707 were less than 1 μM; AM1172 and OMDM-2 exhibited K I values of 3 and 10 μM, respectively. The IC50 values for inhibition of AEA accumulation were compared to the IC50 values for PEA accumulation and AEA hydrolysis using linear regression. None of the regressions were significant. These data indicate that inhibition of AEA accumulation by neurons is not a result of the inhibition of endocannabinoid hydrolysis and is a process different from the accumulation of PEA. These studies support the hypothesis that the cellular AEA accumulation beyond simple equilibrium between intracellular and extracellular concentrations occurs because AEA binds to an intracellular protein that is not FAAH but that also recognizes the AEA uptake inhibitors.

KW - AM1172

KW - AM404

KW - N-arachidonylethanolamine

KW - OMDM-2

KW - Palmitoylethanolamide

KW - UCM707

KW - VDM-11

UR - http://www.scopus.com/inward/record.url?scp=35348851360&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=35348851360&partnerID=8YFLogxK

U2 - 10.1007/s12031-007-0045-0

DO - 10.1007/s12031-007-0045-0

M3 - Article

VL - 33

SP - 18

EP - 24

JO - Journal of Molecular Neuroscience

JF - Journal of Molecular Neuroscience

SN - 0895-8696

IS - 1

ER -